Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • PATIENT  (13)
  • ONCOLOGY  (12)
Collection
Keywords
Publisher
  • 1
    facet.materialart.
    facet.materialart.
    Springer Verlag
    Keywords: radiation ; OPTIMIZATION ; treatment ; TECHNOLOGY ; inverse planning ; ONCOLOGY ; RADIATION ONCOLOGY
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: OPTIMIZATION ; SPECTRA ; radiotherapy ; evaluation ; MODEL ; THERAPY ; SYSTEM ; SYSTEMS ; VOLUME ; RISK ; radiation ; TIME ; PATIENT ; BASE ; treatment ; TARGET ; RADIATION-THERAPY ; adaptive triangulation ; clustering techniques ; multi-criteria optimization ; representative pareto solutions
    Abstract: Radiation therapy planning is often a tightrope walk between dangerous insufficient dose in the target volume and life threatening overdosing of organs at risk. Finding ideal balances between these inherently contradictory goals challenges dosimetrists and physicians in their daily practice. Todays inverse planning systems calculate treatment plans based on a single evaluation function that measures the quality of a radiation treatment plan. Unfortunately, such a one dimensional approach cannot satisfactorily map the different backgrounds of physicians and the patient dependent necessities. So, too often a time consuming iterative optimization process between evaluation of the dose distribution and redefinition of the evaluation function is needed. In this paper we propose a generic multi-criteria approach based on Pareto's solution concept. For each entity of interest - target volume or organ at risk - a structure dependent evaluation function is defined measuring deviations from ideal doses that are calculated from statistical functions. A reasonable bunch of clinically meaningful Pareto optimal solutions are stored in a data base, which can be interactively searched by physicians. The system guarantees dynamic planning as well as the discussion of tradeoffs between different entities. Mathematically, we model the inverse problem as a multi-criteria linear programming problem. Because of the large scale nature of the problem it is not possible to solve the problem in a 3D-setting without adaptive reduction by, appropriate approximation schemes. Our approach is twofold: First, the discretization of the continuous problem results from an adaptive hierarchical clustering process which is used for a local refinement of constraints during the optimization procedure. Second, the set of Pareto optimal solutions is approximated by an adaptive grid of representatives that are found by a hybrid process of calculating extreme compromises and interpolation methods
    Type of Publication: Journal article published
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: CANCER ; radiotherapy ; tumor ; carcinoma ; Germany ; THERAPY ; CT ; FOLLOW-UP ; imaging ; SURGERY ; radiation ; PATIENT ; prognosis ; CONTRAST ; RADIATION-THERAPY ; chemotherapy ; DELIVERY ; AD ; ESOPHAGUS ; RANDOMIZED-TRIAL ; IMRT ; radiology ; GUIDANCE ; THERAPIES ; LIBRARIES ; chemoradiation ; radiation therapy ; CT SCANS ; LIBRARY ; ESOPHAGEAL CANCER ; IMAGE GUIDANCE ; JUNCTION ; ATRIAL-FIBRILLATION ; outcome ; GUIDED RADIOTHERAPY ; RADIOCHEMOTHERAPY ; POSITION ; SCAN ; STRATEGY ; LIMITATIONS ; Esophageal carcinoma
    Abstract: Background: Despite maximum therapy the prognosis of esophageal carcinoma still remains extremely poor. New treatment strategies including improved radiation therapy techniques promise better outcome by improving local control through precise dose delivery due to higher conformality. Case Report: A 62-year-old patient with locally advanced carcinoma of the gastroesophageal junction underwent definitive radiochemotherapy with intensity-modulated radiation therapy (IMRT). On positioning control with the in-room CT, the distal. esophagus, and hence the tumor, was found to be highly mobile exhibiting changes in position of up to 4 cm from fraction to fraction. Result: IMRT plans were created for various positions establishing a plan library to choose from as appropriate. CT scans were performed prior to each treatment fraction to clarify esophagus position in order to choose the adequate treatment plan. Conclusion. Image guidance was crucial in this unusual case of esophageal carcinoma. Without the information from position control CTs, the tumor would have received only about half the prescribed dose due to variations in position. For this specific case, in-room CT scans are probably superior to kilo- or megavoltage CTs due to the higher soft-tissue contrast enabling detection of positioning variation of the organ and offering the possibility to use the CT for treatment planning
    Type of Publication: Journal article published
    PubMed ID: 19714309
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: radiotherapy ; LUNG ; THERAPY ; ALGORITHM ; IMAGES ; RISK ; ACCURACY ; validation ; radiation ; PATIENT ; ASSOCIATION ; RADIATION-THERAPY ; UNCERTAINTY ; sensitivity ; DEFORMABLE IMAGE REGISTRATION ; ERRORS ; 4D CT IMAGES ; b-spline registration ; dose accumulation ; dose mapping ; fractionated radiation therapy
    Abstract: Purpose: In fractionated radiation therapy, image guidance with daily tomographic imaging becomes more and more clinical routine. In principle, this allows for daily computation of the delivered dose and for accumulation of these daily dose distributions to determine the actually delivered total dose to the patient. However, uncertainties in the mapping of the images can translate into errors of the accumulated total dose, depending on the dose gradient. In this work, an approach to estimate the uncertainty of mapping between medical images is proposed that identifies areas bearing a significant risk of inaccurate dose accumulation.Methods: This method accounts for the geometric uncertainty of image registration and the heterogeneity of the dose distribution, which is to be mapped. Its performance is demonstrated in context of dose mapping based on b-spline registration. It is based on evaluation of the sensitivity of dose mapping to variations of the b-spline coefficients combined with evaluation of the sensitivity of the registration metric with respect to the variations of the coefficients. It was evaluated based on patient data that was deformed based on a breathing model, where the ground truth of the deformation, and hence the actual true dose mapping error, is known.Results: The proposed approach has the potential to distinguish areas of the image where dose mapping is likely to be accurate from other areas of the same image, where a larger uncertainty must be expected.Conclusions: An approach to identify areas where dose mapping is likely to be inaccurate was developed and implemented. This method was tested for dose mapping, but it may be applied in context of other mapping tasks as well.
    Type of Publication: Journal article published
    PubMed ID: 22482640
    Signatur Availability
    BibTip Others were also interested in ...
  • 5
    Keywords: CANCER ; radiotherapy ; tumor ; COMBINATION ; Germany ; LUNG ; PROSTATE ; ALGORITHM ; CT ; imaging ; INFORMATION ; lung cancer ; LUNG-CANCER ; MASK ; TISSUE ; TIME ; PATIENT ; COMPLEX ; COMPLEXES ; CONTRAST ; treatment ; TARGET ; ACQUISITION ; EXPERIENCE ; VECTOR ; NUMBER ; prostate cancer ; PROSTATE-CANCER ; REGISTRATION ; BEAM ; DELIVERY ; HEAD ; CANCER-PATIENTS ; MULTILEAF COLLIMATOR ; treatment planning ; BODY ; CANCER PATIENTS ; LINEAR-ACCELERATOR ; RECONSTRUCTION ; IMRT ; PATIENT FIXATION ; IMPLEMENTATION ; INCREASE ; chordoma ; LEVEL ; methods ; fractionated stereotactic radiotherapy ; technique ; MUTUAL INFORMATION ; cancer research ; cone beam CT ; LANDMARK ; INCREASES ; CLINICAL IMPLEMENTATION ; ACCELERATOR ; WORKLOAD
    Abstract: ABSTRACT: BACKGROUND: The purpose of the study was the clinical implementation of a kV cone beam CT (CBCT) for setup correction in radiotherapy. PATIENTS AND METHODS: For evaluation of the setup correction workflow, six tumor patients (lung cancer, sacral chordoma, head-and-neck and paraspinal tumor, and two prostate cancer patients) were selected. All patients were treated with fractionated stereotactic radiotherapy, five of them with intensity modulated radiotherapy (IMRT). For patient fixation, a scotch cast body frame or a vacuum pillow, each in combination with a scotch cast head mask, were used. The imaging equipment, consisting of an x-ray tube and a flat panel imager (FPI), was attached to a Siemens linear accelerator according to the in-line approach, i.e. with the imaging beam mounted opposite to the treatment beam sharing the same isocenter. For dose delivery, the treatment beam has to traverse the FPI which is mounted in the accessory tray below the multi-leaf collimator. For each patient, a predefined number of imaging projections over a range of at least 200 degrees were acquired. The fast reconstruction of the 3D-CBCT dataset was done with an implementation of the Feldkamp-David-Kress (FDK) algorithm. For the registration of the treatment planning CT with the acquired CBCT, an automatic mutual information matcher and manual matching was used. RESULTS AND DISCUSSION: Bony landmarks were easily detected and the table shifts for correction of setup deviations could be automatically calculated in all cases. The image quality was sufficient for a visual comparison of the desired target point with the isocenter visible on the CBCT. Soft tissue contrast was problematic for the prostate of an obese patient, but good in the lung tumor case. The detected maximum setup deviation was 3 mm for patients fixated with the body frame, and 6 mm for patients positioned in the vacuum pillow. Using an action level of 2 mm translational error, a target point correction was carried out in 4 cases. The additional workload of the described workflow compared to a normal treatment fraction led to an extra time of about 10-12 minutes, which can be further reduced by streamlining the different steps. CONCLUSION: The cone beam CT attached to a LINAC allows the acquisition of a CT scan of the patient in treatment position directly before treatment. Its image quality is sufficient for determining target point correction vectors. With the presented workflow, a target point correction within a clinically reasonable time frame is possible. This increases the treatment precision, and potentially the complex patient fixation techniques will become dispensable
    Type of Publication: Journal article published
    PubMed ID: 16723023
    Signatur Availability
    BibTip Others were also interested in ...
  • 6
    Keywords: tumor ; COMBINATION ; evaluation ; Germany ; THERAPY ; CT ; FOLLOW-UP ; imaging ; VOLUME ; DISEASE ; NEW-YORK ; validation ; NUCLEAR-MEDICINE ; PATIENT ; MRI ; SEQUENCE ; SEQUENCES ; chemotherapy ; VARIABILITY ; FUNCTION TESTS ; MOTION ; nuclear medicine ; mesothelioma ; PLEURAL MESOTHELIOMA ; dynamic MRI ; radiology ; malignant pleural mesothelioma ; THERAPIES ; IMAGING TECHNIQUES ; WEIGHT ; breathing cycle ; NUCLEAR ; CRITERIA ; technique ; USA ; correlation ; MEDICINE ; comparison ; KAPPA ; VALUES ; INTEROBSERVER ; RECIST ; RECIST CRITERIA ; MPM ; tumour volumetry
    Abstract: To evaluate and compare early therapy response according to RECIST (response evaluation criteria in solid tumours) and modified RECIST criteria using MRI techniques in patients with malignant pleural mesothelioma (MPM) in comparison with CT. Fifty patients with MPM (32 male/18 female) were included in this study. Early therapy response was evaluated after 9 weeks [three of six chemotherapy (CHT)] cycles. Additionally patients were examined before chemotherapy, 4 weeks after early therapy response evaluation and after six cycles to evaluate diagnostic follow-up. RECIST and modified RECIST criteria were applied using CT and MRI (HASTE, VIBE, T2-TSE sequences). In MRI additionally a volumetric approach measuring tumour weight (overall segmented tumour volume) was applied. Additionally vital capacity (VC) was measured for correlation. Image interpretation was performed by three independent readers independently and in consensus. The 'gold standard' was follow-up examination. Twenty-eight patients showed partial response, 12 patients stable disease and 10 patients progressive disease at early therapy response evaluation. In the follow-up these results remained. For MRI, in 46 cases patients were identically classified using RECIST and modified RECIST criteria. Modified RECIST criteria were identically classified as gold standards in all cases, whereas using RECIST criteria in four cases there was a mismatch (partial response vs. stable disease). Modified RECIST kappa values showed better interobserver variability compared with RECIST criteria (kappa=0.9-1.0 vs. 0.7-1.0). For CT, in 44 cases patients were identically classified using RECIST and modified RECIST criteria. Modified RECIST criteria were identically classified as in gold standards in 48 out of 50 patients, whereas using RECIST criteria in 6 cases there was a mismatch (partial response vs. stable disease). Modified RECIST kappa values showed better interobserver variability compared with RECIST criteria (kappa=0.9-1.0 vs. 0.6-1.0). Modified RECIST criteria especially in combination with high-resolution MRI is a very accurate and reproducible technique to correctly evaluate early therapy response in MPM
    Type of Publication: Journal article published
    PubMed ID: 18369634
    Signatur Availability
    BibTip Others were also interested in ...
  • 7
    Keywords: CELLS ; radiotherapy ; SURVIVAL ; tumor ; CELL ; Germany ; neoplasms ; THERAPY ; TOXICITY ; FOLLOW-UP ; DISEASE ; TUMORS ; SURGERY ; radiation ; MRI ; PROGRESSION ; CONFORMAL RADIOTHERAPY ; EXPERIENCE ; RADIATION-THERAPY ; AGE ; EFFICACY ; REGION ; HEAD ; NECK ; local control ; ONCOLOGY ; overall survival ; radiation therapy ; MENINGIOMAS ; BONE ; SCAN ; INSTITUTION ; CASE SERIES
    Abstract: Background: Giant cell tumors are rare neoplasms, representing less than 5% of all bone tumors. The vast majority of giant cell tumors occurs in extremity sites and is treated by surgery alone. However, a small percentage occurs in pelvis, spine or skull bones, where complete resection is challenging. Radiation therapy seems to be an option in these patients, despite the lack of a generally accepted dose or fractionation concept. Here we present a series of five cases treated with high dose IMRT. Patients and Methods: From 2000 and 2006 a total of five patients with histologically proven benign giant cell tumors have been treated with IMRT in our institution. Two patients were male, three female, and median age was 30 years (range 20 - 60). The tumor was located in the sacral region in four and in the sphenoid sinus in one patient. All patients had measurable gross disease prior to radiotherapy with a median size of 9 cm. All patients were treated with IMRT to a median total dose of 64 Gy (range 57.6 Gy to 66 Gy) in conventional fractionation. Results: Median follow up was 46 months ranging from 30 to 107 months. Overall survival was 100%. One patient developed local disease progression three months after radiotherapy and needed extensive surgical salvage. The remaining four patients have been locally controlled, resulting in a local control rate of 80%. We found no substantial tumor shrinkage after radiotherapy but in two patients morphological signs of extensive tumor necrosis were present on MRI scans. Decline of pain and/or neurological symptoms were seen in all four locally controlled patients. The patient who needed surgical salvage showed markedly reduced pain but developed functional deficits of bladder, rectum and lower extremity due to surgery. No severe acute or late toxicities attributable to radiation therapy were observed so far. Conclusion: IMRT is a feasible option in giant cells tumors not amendable to complete surgical removal. In our case series local control was achieved in four out of five patients with marked symptom relief in the majority of cases. No severe toxicity was observed
    Type of Publication: Journal article published
    PubMed ID: 20187955
    Signatur Availability
    BibTip Others were also interested in ...
  • 8
    Keywords: Germany ; LUNG ; PERFUSION ; THERAPY ; FOLLOW-UP ; imaging ; VOLUME ; DISEASE ; PATIENT ; MRI ; CYCLE ; magnetic resonance imaging ; MOBILITY ; chemotherapy ; FUNCTION TESTS ; MOTION ; PLEURAL MESOTHELIOMA ; dynamic MRI ; 2D ; breathing cycle ; DIAPHRAGM ; HEALTHY-SUBJECTS ; SPIROMETRY ; volumetry ; LUNG-VOLUME ; therapy monitoring ; 3D volumetry
    Abstract: Purpose: To monitor lung motion in patients with malignant pleural mesothelioma (MPM) before and after chemotherapy (CHT) using 2-dimensional (2D) and 3-dimensional (3D) dynamic MRI (dMRI) in comparison with spirometry. Methods and Materials: Twenty-two patients with MPM were examined before CHT, as well as after 3 and 6 CHT cycles (3 months and 6 months) using 2D dMRI (trueFISP; 3 images/s) and 3D dMRI (FLASH 3D, I slab (52 slices)/s) using parallel imaging in combination with view-sharing technique. Maximum craniocaudal lung dimensions (2D) and lung volumes (3D) were monitored, separated into the tumor-bearing and nontumor-bearing hemithorax. Vital capacity (VC) was measured for comparison using spirometry. Results: Using 2D technique, there was a significant difference between the tumor-bearing and the nontumor-bearing hemithorax before CHT (P 〈 0.01) and after 3 CHT cycles (P 〈 0.05), whereas difference was not significant in the second control. In the tumor-bearing hemithorax, mobility increased significantly from the status before versus after 3 CHT cycles (4.1 +/- 1.1 cm vs. 4.8 +/- 1.4 cm, P 〈 0.05). Using 3D technique, at maximum inspiration, the volume of the tumor-bearing hemithorax was 0.6 +/- 0.4 L and of the nontumor-bearing hemithorax 1.25 +/- 0.4 L before CHT. In the follow-up exams, these volumes changed to 1.05 +/- 0.4 L (P 〈 0.05) and 1.4 +/- 0.5 L, respectively. Using spirometry, there was no significant change in VC (1.9 +/- 0.4 L vs. 2.2 +/- 0.7 L vs. 2.2 +/- 0.9 L). Conclusion: dMRI is capable of monitoring changes in lung, motion and volumetry in patients with MPM not detected by global spirornetry. Thus, dMRI is proposed for use as a further measure of therapy response
    Type of Publication: Journal article published
    PubMed ID: 16625107
    Signatur Availability
    BibTip Others were also interested in ...
  • 9
    Keywords: IRRADIATION ; Germany ; IN-VIVO ; SYSTEM ; RESOLUTION ; radiation ; PATIENT ; treatment ; RADIATION-THERAPY ; ENERGY ; LINE ; IONIZATION ; INTENSITY-MODULATED RADIOTHERAPY ; LINEAR-ACCELERATOR ; IMRT ; in vivo ; TRANSMISSION ; CLINICAL IMPLEMENTATION ; DIODE DOSIMETRY ; ROUTINE QUALITY-ASSURANCE
    Abstract: Permanent in vivo verification of IMRT photon beam profiles by a radiation detector with spatial resolution, positioned on the radiation entrance side of the patient, has not been clinically available so far. In this work we present the DAVID system, which is able to perform this quality assurance measurement while the patient is treated. The DAVID system is a flat, multi-wire transmission-type ionization chamber, placed in the accessory holder of the linear accelerator and constructed from translucent materials in order not to interfere with the light field. Each detection wire of the chamber is positioned exactly in the projection line of a MLC leaf pair, and the signal of each wire is proportional to the line integral of the ionization density along this wire. Thereby, each measurement channel essentially presents the line integral of the ionization density over the opening width of the associated leaf pair. The sum of all wire signals is a measure of the dose-area product of the transmitted photon beam and of the total radiant energy administered to the patient. After the dosimetric verification of an IMRT plan, the values measured by the DAVID system are stored as reference values. During daily treatment the signals are re-measured and compared to the reference values. A warning is output if there is a deviation beyond a threshold. The error detection capability is a leaf position error of less than I mm for an isocentric I cm x I cm field, and of I mm for an isocentric 20 cm x 20 cm field
    Type of Publication: Journal article published
    PubMed ID: 16481690
    Signatur Availability
    BibTip Others were also interested in ...
  • 10
    Keywords: OPTIMIZATION ; radiotherapy ; evaluation ; Germany ; human ; PROSTATE ; ALGORITHM ; imaging ; SYSTEM ; VISUALIZATION ; meningioma ; NUCLEAR-MEDICINE ; TIME ; PATIENT ; QUALITY ; REDUCTION ; treatment ; FORM ; ELEMENT ; NO ; TRIAL ; RADIATION-THERAPY ; DATABASE ; BEAM ; INTENSITY-MODULATED RADIOTHERAPY ; sensitivity ; nuclear medicine ; IMRT ; radiology ; ONCOLOGY ; PROGRAM ; sensitivity analysis ; RE ; REAL-TIME ; interaction ; intensity modulated radiotherapy ; analysis ; methods ; NUCLEAR ; navigation ; BRACHYTHERAPY ; MEDICINE ; NOV ; user interface ; ERROR ; clinical evaluation ; DOSE OPTIMIZATION ; interactive ; inverse planning system ; multiobjective ; mutticriteria
    Abstract: Background and purpose: Currently, inverse planning for intensity-modulated radiotherapy (IMRT) can be a timeconsuming trial and error process. This is because many planning objectives are inherently contradictory and cannot reach their individual optimum all at the same time. Therefore in clinical practice the potential of IMRT cannot be fully exploited for all patients. Multicriteria (multiobjective) optimization combined with interactive plan navigation is a promising approach to overcome these problems. Patients and methods: We developed a new inverse planning system called "Multicriteria Interactive Radiotherapy Assistant (MIRA)". The optimization result is a database of patient specific, Pareto-optimal plan proposals. The database is explored with an intuitive user interface that utilizes both a new interactive element for plan navigation and familiar dose visualizations in form of DVH and isoclose projections. Two clinical test cases, one paraspinal meningioma case and one prostate case, were optimized using MIRA and compared with the clinically approved planning program KonRad. Results: Generating the databases required no user interaction and took approx. 2-3 h per case. The interactive exploration required only a few minutes until the best plan was identified, resulting in a significant reduction of human planning time. The achievable plan quality was comparable to KonRad with the additional benefit of having plan alternatives at hand to perform a sensitivity analysis or to decide for a different clinical compromise. Conclusions: The MIRA system provides a complete database and interactive exploration of the solution space in real time. Hence, it is ideally suited for the inherently multicriterial problem of inverse IMRT treatment planning. (c) 2007 Elsevier Ireland Ltd. All rights reserved
    Type of Publication: Journal article published
    PubMed ID: 17892901
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...